Table 2.
Painease® n=49 |
Ice n=45 |
p value | |
---|---|---|---|
Subject VAS-S | |||
Baseline | 35 (2, 69) | 22 (0, 62) | p=0.18 |
Treatment | 4 (1, 19) | 15 (2, 32) | p=0.13 |
IV Placement | 9 (2, 24) | 13 (3, 42) | p=0.08 |
Investigator VAS-I | |||
Baseline | 4 (2, 11) | 3 (0, 5) | p=0.0398 |
Treatment | 1 (0, 3) | 3 (0, 11) | p=0.0477 |
IV Placement | 2 (0, 7) | 4 (2, 16) | p=0.0086 |
Video Reviewers * | |||
IV Placement | 0.5 (0, 7) | 2 (0, 6.5) | p=0.25 |
Subject Δ VAS-S | |||
Δ Treatment - Baseline | −20 (−60, 1) | 0 (−28, 10) | p=0.0356 |
Δ IV - Baseline | −20 (−56, 0) | 0 (−38, 19) | p=0.0127 |
Δ IV - Baseline | 0 (−8, 9) | 2 (−11, 12) | p=0.77 |
For video reviewers Painease® n=34, Ice n=32